Skip to main content
ACTRIS will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 to check if you are unsure if something is a scam or visit ScamShield (opens in new tab) for more information.

Advanced Cell Therapy and Research Institute, Singapore (ACTRIS)

Prof Chng Wee Joo

About Prof Chng Wee Joo

Last updated 16 September 2026
Smiling man with glasses wearing a dark suit, light blue shirt, and blue patterned tie against a light gray tile background.

Affiliations

Executive Director, Singapore Translational Cancer Consortium

Vice President (Biomedical Sciences Research), Office of the Deputy President (Research & Technology) & Senior Principal Investigator, Cancer Science Institute of Singapore, National University of Singapore

Senior Consultant, National University Cancer Institute, Singapore

Group Chief Scientist, National University Health System

Profile

Professor Chng Wee Joo is Executive Director of the Singapore Translational Cancer Consortium. A haemotologist by training, he has been a Senior Consultant at the National University Cancer Institute, Singapore for over two decades and currently serves as Group Chief Scientist at the National University Health System.

Presently the Yong Loo Lin Professor in Medical Oncology, Professor Chng is Vice President (Biomedical Sciences Research) at the National University of Singapore, where he is also a Senior Principal Investigator of the Cancer Science Institute of Singapore.

Professor Chng is the chair of the Asian Myeloma Network, a member of various leading national and international professional committees, including the International Myeloma Working Group and the American Society of Hematology, and a former president of the Singapore Society of Hematology. In addition, he serves on several advisory boards, steering committees for international clinical trials, grant review panels, and conference organizing committees. He has authored over 400 publications in several reputable journals, actively engages in clinical trials, and has given multiple talks at important conferences and seminars. His impactful research has won him numerous national and global accolades including the NUHS Research Excellence Award, the International Myeloma Foundation’s Brian GM Durie Outstanding Achievement Award, the National Medical Excellence Outstanding Clinician Scientist Award, the National Medical Research Council Senior Translational Research (STaR) Award, the National University of Singapore Young Researcher Award, and the Celgene Future Leaders in Haematology Award.